Pediatrix Medical Group, Inc. $MD Shares Acquired by Teacher Retirement System of Texas

Teacher Retirement System of Texas increased its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 25.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 306,715 shares of the company’s stock after buying an additional 62,446 shares during the period. Teacher Retirement System of Texas owned about 0.36% of Pediatrix Medical Group worth $6,561,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of MD. Blue Trust Inc. acquired a new position in shares of Pediatrix Medical Group in the 4th quarter valued at about $37,000. KBC Group NV bought a new stake in Pediatrix Medical Group in the 4th quarter valued at about $65,000. Canada Pension Plan Investment Board bought a new stake in Pediatrix Medical Group in the 2nd quarter valued at about $83,000. Quantbot Technologies LP bought a new stake in Pediatrix Medical Group in the 2nd quarter valued at about $99,000. Finally, Smartleaf Asset Management LLC lifted its position in Pediatrix Medical Group by 10.6% in the 3rd quarter. Smartleaf Asset Management LLC now owns 6,250 shares of the company’s stock valued at $101,000 after purchasing an additional 601 shares during the last quarter. 97.71% of the stock is owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Up 0.1%

MD stock opened at $23.06 on Monday. Pediatrix Medical Group, Inc. has a 52 week low of $11.84 and a 52 week high of $24.99. The company has a market capitalization of $1.92 billion, a price-to-earnings ratio of 11.89 and a beta of 0.72. The firm’s 50-day moving average is $20.83 and its two-hundred day moving average is $21.02. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.66.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Thursday, February 19th. The company reported $0.50 EPS for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.03). Pediatrix Medical Group had a return on equity of 19.59% and a net margin of 8.64%.The business had revenue of $493.77 million during the quarter, compared to the consensus estimate of $486.23 million. During the same quarter in the previous year, the firm earned $0.51 earnings per share. The firm’s revenue for the quarter was down 1.7% compared to the same quarter last year. On average, analysts forecast that Pediatrix Medical Group, Inc. will post 2.05 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on MD shares. UBS Group cut their price objective on shares of Pediatrix Medical Group from $23.00 to $22.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 24th. Deutsche Bank Aktiengesellschaft set a $19.00 price objective on shares of Pediatrix Medical Group in a research report on Friday, February 20th. Zacks Research downgraded shares of Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 23rd. Jefferies Financial Group restated a “buy” rating and set a $27.00 price target on shares of Pediatrix Medical Group in a research report on Monday, April 20th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Friday, March 27th. Two equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $21.33.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.